ENTR logo

ENTR ETF

Profile

Name:

ERShares Private-Public Crossover ETF

Assets under management:

$80 M

Expense ratio:

0.75%

Inception date:

08 November 2017

Website:

-

Last ex-dividend date:

21 December 2021

Next ex-dividend date:

N/A

Description:

The ENTR ETF is an exchange-traded fund that focuses on companies involved in the entertainment and media sectors. It offers investors a way to gain exposure to a diverse range of businesses, including streaming services, gaming, and content production, aiming for growth in this dynamic industry.

Top holdings

Name
Weight
SQ logo
Block(SQ)
5.73 %
GOOGL logo
Alphabet(GOOGL)
5.00 %
NVDA logo
NVIDIA(NVDA)
3.82 %
FTNT logo
Fortinet(FTNT)
3.34 %
SNPS logo
Synopsys(SNPS)
3.33 %
ORCL logo
Oracle(ORCL)
3.27 %
TWLO logo
Twilio(TWLO)
3.19 %
NET logo
Cloudflare(NET)
3.14 %
CRWD logo
CrowdStrike Holdings(CRWD)
3.11 %
COF logo
Capital One Financial(COF)
2.78 %

Holding types

Countries

Sectors

Analyst ratings

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

$18.40
ENTR price is $18.40

Price YTD Change

+36.09%
ENTR price is up +36.09% since January 1st

Price All-time High

$31.70
ENTR price is currently -41.95% below its historical high of $31.70

200-day SMA

$15.59
ENTR 200-day simple moving average is currently +18.02% above its 200-day simple moving average

50-day SMA

$16.95
ENTR 50-day simple moving average is currently +8.54% above its 50-day simple moving average

14-day RSI

66.70
ENTR 14-day relative strength index is 66.70

ATR

$0.27
ENTR average true range is $0.27

Beta

1.58
ENTR beta is 1.58

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Last Paid Dividend

$8.73
ENTR dividend per share is $8.73
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy
ENTR
globenewswire.com24 June 2024

– ENTR-601-44 was well-tolerated in healthy volunteers with no serious adverse events, no drug-related adverse events and no clinically significant changes or trends noted in vital signs, ECGs, physical exams or laboratory assessments –

ETF of the Week: ERShares Entrepreneurs ETF (ENTR)
ETF of the Week: ERShares Entrepreneurs ETF (ENTR)
ETF of the Week: ERShares Entrepreneurs ETF (ENTR)
ENTR
ETF Trends06 April 2023

VettaFi's vice chairman Tom Lydon discussed the ERShares Entrepreneurs ETF (ENTR) on this week's “ETF of the Week” podcast with Chuck Jaffe of “Money Life.” Entrepreneurial companies are on fire, positioning the ERShares Entrepreneurs ETF (ENTR) among the rising ETFs.

FAQ

  • What is ENTR ETF?
  • Does ENTR pay dividends?
  • What stocks are in ENTR ETF?
  • What is the current assets under management for ENTR?
  • What is ENTR average volume?
  • What is ENTR expense ratio?
  • What is ENTR inception date?

What is ENTR ETF?

The ENTR ETF is an exchange-traded fund that focuses on companies involved in the entertainment and media sectors. It offers investors a way to gain exposure to a diverse range of businesses, including streaming services, gaming, and content production, aiming for growth in this dynamic industry.

Does ENTR pay dividends?

Yes, the ERShares Private-Public Crossover ETF does pays dividends, with the most recent payment being $8.73 per share. The last ex-dividend date was on 21 December 2021, and the next ex-dividend date has not been announced yet

What stocks are in ENTR ETF?

As of today, ERShares Private-Public Crossover ETF inlcudes 45 holdings, with 43 of them being companies from 1 different countries and 8 sectors. The most weighted holdings are Block (5.73%), Alphabet (5%) and NVIDIA (3.82%)

What is the current assets under management for ENTR?

Assets under management of ERShares Private-Public Crossover ETF is $80 M

What is ENTR average volume?

Average volume of ERShares Private-Public Crossover ETF is $4441

What is ENTR expense ratio?

Expense ratio of ERShares Private-Public Crossover ETF is 0.75%

What is ENTR inception date?

Inception date of ERShares Private-Public Crossover ETF is 08 November 2017